Faculty

Barbara J. Coffey, MD, MS Division Chief, Child and Adolescent Psychiatry Director, UHealth Tics, OCD and Related Problems Professor, Department of Psychiatry and Behavioral Sciences University of Miami, Miller School of Medicine Miami, FL

Statement of Need

This video is a replay of a plenary session from the 11th Annual Chair Summit Master Class for Neuroscience Professional Development held in Ft. Lauderdale, FL on February 7-9, 2019.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Apply DSM-5 criteria and validated rating scales in the assessment of ADHD in children, adolescents, and adults.
• Apply best practices for minimizing side effects associated with traditional stimulants used to treat ADHD.
• Evaluate clinical trial data for new or emerging agents with novel MOAs to treat ADHD in children, adolescents, and adults.

• Describe DSM-5 criteria and validated rating scales for the assessment of ADHD in children, adolescents, and adults.
• Identify best practices for minimizing side effects associated with traditional stimulants used to treat ADHD.
• Describe clinical trial data for new or emerging agents with novel MOAs to treat ADHD in children, adolescents, and adults.

Financial Support

This activity is supported by an educational grant from Shire, now part of Takeda.

Target Audience

Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other non-physician health care professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hours. 

Note to Nurse Practitioners: Nurses can apply for AMA PRA Category 1 Credit^TM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit^TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hours (0.10) CEUs). Universal Activity Number: Enduring: 0376-000019-037-H01-P

Type: knowledge-based.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit^TM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Coffey reports that she receives research support from Neurocrine Biosciences, Inc.; National Institute of Mental Health (NIMH)/University of California San Francisco (UCSF); and Teva Pharmaceutical Industries Ltd./Nuvelution Pharma, Inc. She is on the advisory board of Abide Therapeutics, Inc. and Teva Pharmaceutical Industries Ltd./Nuvelution Pharma, Inc. She receives other financial support from American Academy of Child and Adolescent Psychiatry; Bracket; Cincinnati Children's Hospital; Harvard Medical School/Psychiatry Academy; Nevada Psychiatric Association; Partners Healthcare; Tourette Association of America: Co-Chair, Medical Advisory Board; and TAA-CDC Partnership.

Howard Bliwise, MD (peer reviewer) has no disclosures to report.

Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS(877.263.7767).

CHV-082-072619-19